Explore / Peer-reviewed article
Peer-reviewed articleOpen access

Inflammatory biomarker outcomes associated with MDMA-assisted therapy: an open-label exploratory study.

Kachmarik JE, Loftis JM, Stauffer CS

Frontiers in neuroscienceMar 23, 2026License: open accessUnited States0 citationsDOI: 10.3389/fnins.2026.1716817

Abstract

<h4>Background</h4>Posttraumatic stress disorder (PTSD) is associated with elevated inflammation and risk for chronic illness, yet few studies have examined inflammatory biomarker outcomes of PTSD interventions. Rapid PTSD symptom reduction has been observed following 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy, which leverages MDMA as a prosocial adjunct to psychotherapy. No studies have evaluated inflammatory biomarker outcomes of MDMA-assisted therapy. This exploratory pilot study examined within-person changes in inflammatory biomarkers during MDMA-assisted group therapy for Veterans with PTSD (www.clinicaltrials.gov, NCT05961527).<h4>Methods</h4>Blood plasma samples were collected from 23 Veterans at baseline and end-of-intervention. Hedges' g effect sizes were calculated for interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and C-reactive protein (CRP). PTSD severity was assessed with the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) at baseline and 30-day follow-up. Spearman's rho correlations were calculated among biomarkers, PTSD symptoms, and change scores.<h4>Results</h4>Small increases were observed in IL-6 (<i>g</i> = 0.24; 95% CI -0.25, 0.72) and CRP (<i>g</i> = 0.23; 95% CI -0.30, 0.74), and a small decrease in TNF-α (<i>g</i> = -0.24; 95% CI -0.69, 0.23). Baseline IL-6 and TNF-α were positively associated with baseline CAPS-5 scores (ρ = 0.45, 0.32). Higher baseline IL-6 weakly predicted symptom improvement (ρ = -0.25), and IL-6 change correlated with symptom change (ρ = 0.41). CRP showed weak negative associations with PTSD symptoms (ρ = -0.26).<h4>Conclusion</h4>Findings suggest MDMA-assisted therapy may modulate inflammatory biomarkers and highlight biomarker-symptom relationships. Results are preliminary but may inform larger studies.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

MDMAPTSD

Keywords

IL-6InflammationTNF-αVeteransPosttraumatic Stress DisorderCrpInflammatory Markers

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

This study's objects

Directly linked records, matched by DOI, trial reference, or registry, not just topic.